Navigation Links
Sysmex America Announces Amerinet Urinalysis Contract
Date:7/8/2010

MUNDELEIN, Ill., July 8 /PRNewswire/ -- Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source urinalysis contract agreement with Amerinet.  Amerinet members have immediate purchasing/leasing access to Sysmex automated urine particle analyzers, reagents, controls, and service.  Training and technical support for Amerinet members will be provided through Sysmex America's U.S. headquarters in Mundelein, Illinois.  The contract which was awarded on technical merit and pricing also includes Sysmex e-Tools™, a comprehensive set of systems and resources that support a clinical laboratory's long-term success before, during and after instrument or system implementation.  Amerinet is a leading national healthcare group purchasing organization that strategically partners with more than 41,000 healthcare providers to reduce costs and improve quality.

"We at Sysmex America are especially pleased to serve as Amerinet's partner in supporting their member-laboratories' needs to automate microscopic urinalysis – typically a very time-consuming endeavor when performed manually.  We trust that Amerinet members will embrace the reliability and uptime of our instruments as they work to provide high quality, cost-effective patient care in a competitive healthcare environment," said John Kershaw, President & CEO, Sysmex America, Inc.  

As proven with other laboratory disciplines, automation provides for standardized, high-quality results that can be reported in a timely fashion for urine samples as well.  Sysmex developed the first fully automated urine cell analyzer in the world – the Sysmex UF-100™, making its debut in Japan in 1995 and in the United States in 1996.  Since that time, Sysmex introduced its UF-1000i™ automated urine particle analyzer.  The Sysmex UF-1000i combines the advanced technology of fluorescent flow cytometry with fully automated urine sample analysis, providing walk away capability and standardization.  

About Amerinet

As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems.  Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.  For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sysmex America Announces Executive Leadership Changes
2. Sysmex America Honored Second Consecutive Year as a Company That Cares
3. Sysmex America Adds Industry Veteran to Company Leadership
4. OhioHealth Installs Newest Version of Sysmexs Hematology Middleware, Sysmex WAM(TM) 4.0
5. Exagen Diagnostics Receives Lab Accreditation From College of American Pathologists
6. Profil Institute Teams Up With American Diabetes Association to Step Out Against Diabetes
7. Hot Times in the City: As Summer Temperatures Soar, Pulse of Passion Survey Reveals What Makes Americans Sizzle in Relationships
8. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
9. Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
10. Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society
11. InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Proliant Biologicals is proud ... Serum Albumin (BSA) manufacturing facility.  The facility is located ... , in Feilding. Boone ... to functionally duplicate the systems in the U.S. facility, ... used for U.S. installations.  --> ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... , Feb. 11, 2016  AbbVie, a ... AbbVie Rheumatology Scholarship, designed to provide financial support ... as they pursue higher education goals. Fifteen scholars ... the 2016-2017 school year. The AbbVie Rheumatology Scholarship ... Haas , vice president, corporate social responsibility, brand ...
Breaking Medicine Technology:
(Date:2/11/2016)... Little Rock, AR (PRWEB) , ... February 11, 2016 , ... ... Change in their community by announcing a new fundraiser in support of a local ... agency also hopes the campaign will bring awareness to, and rally support for, all ...
(Date:2/11/2016)... Alexandria, VA (PRWEB) , ... February 11, 2016 , ... ... of its new office in the heart of Old Town at 108 South Columbus ... individuals and businesses the highest level of medical care in the convenience of their ...
(Date:2/11/2016)... ... , ... Husted Kicking has completed its Third Annual Husted Kicking ... 7th, 2016 according to kicking coach Michael Husted. , “This event serves as an ... in Indianapolis,” says Husted. “The NFL uses a third party organization to select players ...
(Date:2/11/2016)... ... February 11, 2016 , ... Research led ... rates of several common cancer screenings, especially among women. Cancer screenings are often ... rates. , The study,“What Does Medicaid Expansion Mean for Cancer Screening and ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th ... Molecular Imaging Congress (WMIC), will be held in New York City, NY on ... Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a greater ...
Breaking Medicine News(10 mins):